CWM
GILD icon

Cordatus Wealth Management’s Gilead Sciences GILD Stock Holding History

Cordatus Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,322
Closed -$884K – 65
2022
Q3 		$884K Buy
14,322
+484
+3% +$30.5K 0.93% 35
2022
Q2 		$855K Buy
13,838
+91
+0.7% +$5.63K 0.4% 90
2022
Q1 		$817K Buy
+13,747
New +$879K 0.29% 122
2020
Q2 		– Sell
-47,229
Closed -$3.53M – 118
2020
Q1 		$3.53M Buy
+47,229
New +$3.26M 2.54% 7

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cordatus Wealth Management's GILD Position: Q4 2022 in Review

Cordatus Wealth Management sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 14,322 shares — an estimated $884K sold.

Cordatus Wealth Management first reported a position in GILD in Q1 2020 and held it in 4 quarters. The position peaked at $3.53M in Q1 2020. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Cordatus Wealth Management reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
  • Cordatus Wealth Management sold 14,322 Gilead Sciences shares in Q4 2022, an estimated $884K.
  • Cordatus Wealth Management first reported a position in Gilead Sciences in Q1 2020 and held it in 4 quarters.
  • Cordatus Wealth Management's Gilead Sciences position peaked at $3.53M in Q1 2020.
  • 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Cordatus Wealth Management's 13F filing for Q4 2022, filed 6 Feb 2023.